BJL
PACB icon

Brighton Jones LLC’s Pacific Biosciences PACB Stock Holding History

Brighton Jones LLC’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.4K Buy
20,491
+6,485
+46% +$9.43K ﹤0.01% 1382
2026
Q1 		$18.5K Buy
+14,006
New +$25.1K ﹤0.01% 1188

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
BLAM
Bourne Lent Asset Management Pawling, New York $289M AUM 30.86% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return

Brighton Jones LLC's PACB Position: Q2 2026 in Review

Brighton Jones LLC increased its Pacific Biosciences (PACB) stake by 46% in Q2 2026, buying an estimated $9.43K and bringing the position to 20,491 shares worth $34.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1382.

Brighton Jones LLC first reported a position in PACB in Q1 2026 and has held it in 2 quarters since. 107 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Brighton Jones LLC held 20,491 shares of Pacific Biosciences worth $34.4K as of Q2 2026.
  • Brighton Jones LLC bought 6,485 Pacific Biosciences shares in Q2 2026, an estimated $9.43K.
  • Pacific Biosciences made up ﹤0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #1382 holding.
  • Brighton Jones LLC first reported a position in Pacific Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 107 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.